Please login to the form below

Not currently logged in

HCP Access

This page shows the latest HCP Access news and features for those working in and with pharma, biotech and healthcare.

NICE recognises Smartinhaler as best practice for asthma care

NICE recognises Smartinhaler as best practice for asthma care

The Medtech Innovation Briefing - designed to accelerate NHS access to innovation in new treatments and diagnostics - reports that the device has also been proven more effective than the current practice in ... The Smartinhaler is priced at £100 per

Latest news

  • Monitoring the social media activity of HCPs Monitoring the social media activity of HCPs

    HCP social media monitoring gives you access to tens of thousands of HCP discussions which can be used like an extensive focus group. ... 3. Monitoring HCP-only conversation typically means less pharmacovigilance and adverse event (AE) reporting issues.

  • Features Archive listing

    Simplifying HCP access to digital information.

  • The right way to go digital

    Either you can contact the HCP directly via a verified email list or you can deliver the messages to a closed, verified-HCP community. ... Remember however that some sites allow access when any number is typed into their landing page.

  • Tighten the loop

    Long-term HCP relationship building. • Round-the-clock access to information and key people for HCPs. ... Relevance of content. • Trustworthiness. • No marketing speak. • Easy to access, navigate and find content. •

  • Critical connections

    To be successful in the dynamic European healthcare marketplace, public relations companies need to have real, first-hand experience in dealing with the challenges, whether they stem from regulations, market access, ... the media, or patient and HCP

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    Simplifying HCP access to digital information. New industry-standards group launched. The life science industry’s commercial model has transformed significantly over the past decade. ... This new standard will improve how life science companies

  • Warning signs Warning signs

    The challenges around call rates, access and inefficiencies in the traditional representative model are well known. ... gaining HCP access.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Who says remote sales can't be personal?

    At OUTiCO, a multi-channel model means having the ‘ immediate’ ability to reach the customer (HCP) through a mix of different channels – whether it’ s face-to-face, phone, screen share ... these individuals with valuable accessibility data to

  • Digital trends in B2B sales - how far behind is Pharma?

    At OUTiCO we have spent the last 5 years refining our sales model and building our own database of HCP contacts. ... We are the first Multi-Channel Sales company in the pharma industry, communicating with Health Care Professional’ s

  • The Holy Grail of HCP Access

    The Holy Grail of HCP Access. This is the data you need to gain access. ... With face-to-face access in decline, digital channels have breathed new life into HCP engagement.

  • The Art of Agile Marketing

    HCP access: Because access rates continue to fall, the moments when we can actually get into dialogue with HCPs become vital.

  • How to access and engage with HCPs effectively

    How to access and engage with HCPs effectively. HCP engagement requires the right mix of voice and content, plus knowledge of the channels to access, to reach the target audience. ... In order to master  HCP engagement, therefore, pharma must understand

More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...